COVID-19 mRNA Vaccine Booster
About the Study
SARS-CoV-2, the strain of coronavirus that causes COVID-19 (coronavirus disease 2019), variants have emerged and are likely to continue to emerge and some variants have the potential to circumvent immunity associated with previous infection or vaccination. This study will investigate the relative vaccine efficacy of mRNA-1283.222 administered as a booster dose 2 in participants aged 12 years and older for the prevention of COVID-19.
Ages
18 and over
Study Topics
Vaccine, COVID-19
See If You Qualify For This Study
Symptoms of COVID-19
Possible symptoms include:
- Fever or chills
- Cough
- Shortness of breath or difficulty breathing
- Fatigue
- Muscle or body aches
- Headache
- New loss of taste or smell
- Sore throat
- Congestion or runny nose
- Nausea or vomiting
- Diarrhea
Learn more about COVID-19 variant symptoms.
Why Participate in this COVID-19 Booster Study?
Qualified participants will receive at no cost
- Study-related physical exams
- Study-related lab work
- Study-related procedures
This research study is enrolling people who:
18 and over
Have NOT received a COVID-19 vaccine or tested positive for COVID-19 within the 90 days of screening visit
Do You Not Meet the Criteria for This Study?
You could still participate in other studies. Contact us to be added to our database and you’ll be notified about our future studies that may be right for you.
